BusinessOtonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement SurgeryBy Nasdaq OMXDec 11, 2015, 12:31 PM UTC
BusinessGino Santini and Daniel Welch Elected to Board of Directors of Intercept PharmaceuticalsBy Nasdaq OMXDec 11, 2015, 12:06 PM UTC
BusinessCynapsus Therapeutics Announces Successful Completion of Bioavailability and Pharmacokinetic Study and Provides Update on European Clinical PlansBy Nasdaq OMXDec 10, 2015, 9:11 PM UTC
BusinessOhr Pharmaceutical Reports Fiscal Year 2015 Financial and Business ResultsBy Nasdaq OMXDec 10, 2015, 9:02 PM UTC
BusinessImmunomedics Reports Continuing Positive Results With Sacituzumab Govitecan in Heavily Pre-Treated Metastatic Triple-Negative Breast Cancer PatientsBy Nasdaq OMXDec 10, 2015, 1:31 PM UTC
BusinessOryzon Genomics Announces Listing on Madrid Stock ExchangeBy Nasdaq OMXDec 10, 2015, 1:16 PM UTC
BusinessKite Pharma Announces Pricing of Public Offering of Common StockBy Nasdaq OMXDec 10, 2015, 1:01 PM UTC
BusinessWaferGen Bio-systems Announces First Commercial Sale of ICELL8(TM) Single-Cell System to Major Global Pharmaceutical CompanyBy Nasdaq OMXDec 10, 2015, 1:01 PM UTC
